LAKEWOOD, Colo.—Isely Charity, a member of the 13D group associated with Natural Grocers (NYSE:NGVC) by Vitamin Cottage, Inc. (NYSE:NGVC), reported the sale of 2,000 shares of the company's common stock. The company, currently valued at nearly $1 billion, has seen its stock surge approximately 176% year-to-date, according to InvestingPro data. The shares were sold on December 10, 2024, at a weighted average price of $43.73, amounting to a total transaction value of $87,460. The sale was executed in multiple trades with prices ranging from $43.58 to $43.85.
Following this transaction, Isely Charity holds 12,290 shares of Natural Grocers by Vitamin Cottage. The filing was signed by Kemper (NYSE:KMPR) Isely under a power of attorney on December 12, 2024.
In other recent news, Natural Grocers by Vitamin Cottage, Inc. disclosed impressive financial results for the fourth quarter and Fiscal Year 2024. The health-centric grocery chain reported a 9.3% increase in net sales for Q4, totaling $322.7 million, and an 8.9% increase in full-year revenue, amounting to $1.24 billion. Additionally, the company's diluted earnings per share rose significantly, from $1.02 to $1.47.
Among recent developments, Natural Grocers achieved a 7.1% growth in daily average comparable store sales in Q4 and marked its 21st consecutive year of positive comparable store sales growth. The company also announced a 20% increase in its quarterly cash dividend to $0.12 per share. In terms of strategic initiatives, Natural Grocers is focused on expanding its Npower rewards program and increasing the presence of its branded products.
Looking ahead, the company plans to open 4-6 new stores and relocate or remodel 2-4 stores in Fiscal Year 2025. It expects daily average comparable store sales growth of 4-6% and projects diluted earnings per share for Fiscal Year 2025 to be between $1.52 and $1.60. Lastly, CFO Todd Dissinger is set to retire at the end of the year, with Richard Helet assuming the role on January 1st.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.